All Stories

  1. The utilization of discharge prescriptions in Germany
  2. Use of fixed-dose combinations for cardiovascular indications from 2018 to 2023: a nationwide population-based study
  3. Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers
  4. Impact of the COVID-19 pandemic on implementation of novel guideline-directed medical therapies for heart failure in Germany: a nationwide retrospective analysis
  5. Hidden sodium in effervescent-tablet dietary supplements and over-the-counter drugs: a comparative cross-sectional study
  6. Not obtaining a medication the first time it is prescribed: primary non-adherence to cardiovascular pharmacotherapy
  7. Association of hydrochlorothiazide treatment compared with alternative diuretics with overall and skin cancer risk: a propensity-matched cohort study
  8. Assessment of the Prescriptions of Systemic Antibiotics in Primary Dental Care in Germany from 2017 to 2021: A Longitudinal Drug Utilization Study
  9. Clinical pharmacy services are reimbursed in Germany: challenges of real world implementation remain
  10. Task sharing in an interprofessional medication management program – a survey of general practitioners and community pharmacists
  11. Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials
  12. Trends in Ezetimibe Prescriptions as Monotherapy or Fixed-Dose Combination in Germany 2012–2021
  13. Oral drugs against COVID-19
  14. Use of fixed-dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia
  15. The AMULET ménage à trois: nurse, telemedicine support, and remote cardiologist
  16. Patients’ perception on generating medication plans in an interprofessional medication management program: a mixed-methods study
  17. Interdisciplinary Physician-Pharmacist Medication Review for Outpatients With Heart Failure: A Subanalysis of the PHARM-CHF Randomized Controlled Trial
  18. Utilization of drugs with reports on potential efficacy or harm on COVID ‐19 before, during, and after the first pandemic wave
  19. The evidence for pharmacist care in outpatients with heart failure: a systematic review and meta‐analysis
  20. Quality Appraisal of Ambulatory Oral Cephalosporin and Fluoroquinolone Use in the 16 German Federal States from 2014–2019
  21. Explosive drug information in the time of COVID-19
  22. Wie wirken Generikaquoten? Eine Analyse am Beispiel der HIV-Infektion
  23. Pharmacists’ perception of educational material to improve patient safety
  24. Primary healthcare policy and vision for community pharmacy and pharmacists in Germany
  25. Pharmacy practice research – A call to action
  26. Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany
  27. Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany
  28. “Dear Doctor” Warning Letter (Rote-Hand-Brief) on Hydrochlorothiazide and Its Impact on Antihypertensive Prescription
  29. Development and implementation of blood pressure screening and referral guidelines for German community pharmacists
  30. The impact of pharmacist/physician care on quality of life in elderly heart failure patients: results of the PHARM‐CHF randomized controlled trial
  31. Revisited: Therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics
  32. Post-mortem analysis of prescription opioids—A follow-up examination by LC–MS/MS with focus on fentanyl
  33. The frequency of photosensitizing drug dispensings in Austria and Germany: a correlation with their photosensitizing potential based on published literature
  34. Trends in dispensing oral emergency contraceptives and safety issues: a survey of German community pharmacists
  35. Letter on ‘Pharmacy‐based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM‐CHF randomized controlled trial’: reply
  36. Pharmacy‐based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM‐CHF randomized controlled trial
  37. Das Projekt PRIMA – Elektronische Erstellung und Aktualisierung von Medikationsplänen als gemeinsame Aufgabe von Ärzten und Apothekern
  38. Comparison of Different Strategies to Measure Medication Adherence via Claims Data in Patients With Chronic Heart Failure
  39. Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk
  40. Drug shortages may compromise patient safety: Results of a survey of the reference pharmacies of the Drug Commission of German Pharmacists
  41. Comparing outpatient oral antibiotic use in Germany and the Netherlands from 2012 to 2016
  42. Elektronisch unterstützte Kooperation ambulant tätiger Ärzte und Apotheker zur Verbesserung der Arzneimitteltherapiesicherheit
  43. Der bundeseinheitliche Medikationsplan in der Praxis
  44. Potentielle Erfolgsindikatoren für die Durchführung von Projekten zur Arzt-Apotheker-Zusammenarbeit – eine systematische Übersicht
  45. PHARMacy-based interdisciplinary program for patients with Chronic Heart Failure (PHARM-CHF): rationale and design of a randomized controlled trial, and results of the pilot study
  46. In search of a standard when analyzing medication adherence in patients with heart failure using claims data: a systematic review
  47. Medication knowledge of patients hospitalized for heart failure at admission and after discharge
  48. Medication adherence and persistence according to different antihypertensive drug classes: A retrospective cohort study of 255,500 patients
  49. Evaluation of pharmaceutical concerns in Germany: frequency and potential reasons
  50. Non-prescription dispensing of emergency oral contraceptives: Recommendations from the German Federal Chamber of Pharmacists [Bundesapothekerkammer].
  51. Evaluating patients’ comprehensibility of a standardized medication plan
  52. Patients’ handling of a standardized medication plan: a pilot study and method development
  53. Erratum to: Medical care and drug-related problems: Do doctors and pharmacists speak the same language?
  54. Medical care and drug-related problems: Do doctors and pharmacists speak the same language?
  55. Adherence to Disease Modifying Drugs among Patients with Multiple Sclerosis in Germany: A Retrospective Cohort Study
  56. Detection of pyrrolizidine alkaloids in German licensed herbal medicinal teas
  57. Age-related medication adherence in patients with chronic heart failure: A systematic literature review
  58. Chronische Herzinsuffizienz: Teufelskreis aus geringer Einnahmetreue von Medikamenten und kardialer Dekompensation
  59. Analyses of drugs stored at home by elderly patients with chronic heart failure
  60. Dosage strength is associated with medication persistence with Ginkgo biloba drug products: a cohort study of ambulatory drug claims data in Germany
  61. Drug-related problems in prescribed medicines in Germany at the time of dispensing
  62. Incidence of thyroid hormone therapy in patients treated with sunitinib or sorafenib: A cohort study
  63. Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics
  64. Treatment duration (persistence) of basal insulin supported oral therapy (BOT) in Type-2 diabetic patients: comparison of insulin glargine with NPH insulin
  65. Adherence to guidelines for antibiotic prophylaxis in surgery patients in German hospitals: a multicentre evaluation involving pharmacy interns
  66. Nature and frequency of drug-related problems in self-medication (over-the-counter drugs) in daily community pharmacy practice in Germany
  67. Generic switch after ramipril patent expiry is not associated with decreased pharmacy refill compliance
  68. Strategien zur Verbesserung der Einnahmetreue von Medikamenten
  69. Development of a classification system for drug-related problems in the hospital setting (APS-Doc) and assessment of the inter-rater reliability
  70. Compliance With Antithrombotic Guidelines in Surgery Patients in German Hospitals
  71. Pharmacist-led intervention study to improve inhalation technique in asthma and COPD patients
  72. Versorgungsmanagement für Menschen mit Asthma – Einbindung der Apotheker
  73. DB2 PERSISTENCE WITH BASAL SUPPORTED ORAL THERAPY—COMPARISON OF INSULIN GLARGINE VERSUS NPH INSULIN
  74. Survey of Drug-Related Problems Identified by Community Pharmacies
  75. Pharmacy interns on the ward—a pilot study
  76. German national drug information service: user satisfaction and potential positive patient outcomes
  77. Community pharmacy-based intervention to improve self-monitoring of blood glucose in type 2 diabetic patien
  78. Safety and usage pattern of an over-the-counter ambroxol cough syrup: a community pharmacy-based cohort study
  79. Pharmaceutical Care in Community Pharmacies: Practice and Research in Germany
  80. Community Pharmacy–Based Pharmaceutical Care for Asthma Patients
  81. Comment: when does pharmaceutical care impact health outcomes? A comparison of community pharmacy-based studies of pharmaceutical care for patients with asthma
  82. Counselling quality in community pharmacies: implementation of the pseudo customer methodology in Germany
  83. Pharmaceutical care, European developments in concepts, implementation, teaching, and research: a review
  84. Pharmaceutical Care Services for Asthma Patients: A Controlled Intervention Study
  85. Lack of Methemoglobinemia with Flutamide
  86. Selbstmedikation - ökonomische sozialpharmakologische und toxikologische Aspekte
  87. Clinical Pharmacokinetics of Alfentanil, Fentanyl and Sufentanil
  88. Pharmacokinetics and effects on intracranial pressure of sufentanil in head trauma patients.